Introduction
After microvascular decompression of cranial nerve V or VII, Surgicel Ò and Tissucol Ò were used in 200 cases at our institution. They were uneventfully inserted between the impinging artery and pons to keep the vessels away from the cranial nerves and against the tentoriun or the dura covering the rocca petrosa. We report a case in which a patient developed delayed hemiparesis and packed Surgicel Ò without blood was found as the only cause of compression.
Case report
A 46-year-old female underwent a microvascular decompression of the left trigeminal nerve for relief of intractable trigeminal neuralgia. A left retrosigmoid craniotomy was performed and a conflict with the main trunk of the anterior-inferior cerebellar artery (AICA) was eliminated. The artery was dissected from its arachnoid adhesions and subsequently laid away from the nerve. As is standard at our institution, Surgicel Ò was packed between the artery and the pons, to keep the vessel against the rocca petrosa, and was covered with a small amount of Tissucol Ò . No perioperative complications were noted. The patient recovered from the anesthesia without neurological deficit or trigeminal pain. Approximately 6 h after surgery, the patient developed progressive right hemiparesis that was limited with, but not reversed by, administration of corticosteroids. The patient immediately underwent a head CT, but the imaging was unremarkable and did not show any intracranial hemorrhage or other visible abnormality. A subsequent MRI showed a limited area of edema and ischemia in the left lateral pons, compressed by an adjacent small mass lesion which appeared slightly hyperintense on T1-weighted images and hypointense on T2-weighted images (Fig. 1) . MR angiography was unremarkable and showed a patent left AICA. The patient underwent immediate reoperation to remove the small mass. The packed Surgicel Ò and Tissucol Ò were completely removed. The hemiparesis improved several hours postoperative and completely resolved within 72 h.
Discussion
Non-absorbable cotton or cellulose surgical sponges do not undergo regeneration or oxidation and should be removed from the patient at the conclusion of the surgical procedure. Twentieth century advances in hemostatic agents and anticoagulatory devices led to the widespread adoption of bio-absorbable Surgicel Ò , which is often left in situ. Preliminary studies suggested that the hemostatic mechanism of Surgicel Ò was mechanical, promoting coagulation through physical pressure, but later studies showed that oxidation of the product causes it to have a very low pH and results in the formation of an artificial clot through a caustic process [6, 9] . The product begins to undergo absorption within 24 h of placement, and is absorbed at a variable rate depending on the amount of the product, type of tissue involved, and degree of tissue perfusion [6, 9] . The presence of giant cells has been reported within 1 week, disappearing with the product 1-2 months after surgery [10] .
Compression of nervous structures by packed Surgicel Ò has been reported in only a few cases after spinal surgery (Table 1) . Banerjee et al. [3] reported the first case of ''surgiceloma'' in 1998 which manifested as cauda equine syndrome. After reoperation, swollen blood-soaked Surgicel Ò was found to be the only cause of compression. Two cases of compressive optic neuropathy were reported in 2005 by Arat et al. [1] , both of which required reoperation.
Four cases of spinal cord compression after thoracotomy were also found in the literature [2, 4, 5] .
Several cases of Surgicel Ò mimicking brain abscesses and recurrent tumors are reported in the literature [7, 8, 10, 11] . According to this writing, no cases of midbrain compression inducing hemiparesis have been reported. A slow rate of fluid absorption or a late introduction of fluid to the packed Surgicel Ò would be consistent with delayed onset of postoperative complications, as seen here. In this case, the early compressive effect of the packed surgical could be explained by the small volume of the subarachnoid cisterns, due to a short trigeminal root and the relatively young age of the patient.
Conclusion
During microvascular decompression of trigeminal and facial nerve, great care should be taken in dissecting arachnoid structures around the impinging vessels, so that the artery can move spontaneously away from the nerve. In patients with a small cisternal space around the pons, due to young age and/or a short trigeminal root, a minimal amount of absorbable material should be used, if at all. In cases of clinically suspected pontine ischemia, this mechanism should be considered.
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